The USPTO has suggested 29 pages-worth of changes to Trademark Trial and Appeal Board practice, including to electronic filing, service and electronic communication, streamlining discovery and pre-trial procedures, and making trials more efficient. A proposal to allow testimony by affidavit has been criticised
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the Danish company’s injunction application